How have INBS shares performed in 2023?

Intelligent Bio Solutions' stock was trading at $3.9980 at the start of the year. Since then, INBS stock has decreased by 93.1% and is now trading at $0.2750. View the best growth stocks for 2023 here .

When is Intelligent Bio Solutions' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 13th 2024. View our INBS earnings forecast .

How were Intelligent Bio Solutions' earnings last quarter?

Intelligent Bio Solutions Inc. (NASDAQ:INBS) released its quarterly earnings data on Wednesday, November, 8th. The company reported ($1.04) EPS for the quarter. The business earned $0.80 million during the quarter. Intelligent Bio Solutions had a negative trailing twelve-month return on equity of 147.23% and a negative net margin of 510.29%.

When did Intelligent Bio Solutions' stock split?

Intelligent Bio Solutions's stock reverse split on Friday, February 10th 2023. The 1-20 reverse split was announced on Friday, February 10th 2023. The number of shares owned by shareholders was adjusted after the market closes on Friday, February 10th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Intelligent Bio Solutions Stock Price, News & Analysis (NASDAQ:INBS)

$0.28

-0.03 (-10.37%)

(As of 12:04 PM ET)

Compare

Today's Range: $0.27
▼
$0.30
50-Day Range: $0.21
▼
$1.34
52-Week Range: $0.20
▼
$32.00

Volume: 669,767 shs
Average Volume: 1.74 million shs
Market Capitalization: $2.40 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Intelligent Bio Solutions MarketRank™ Stock Analysis

Analyst Rating: N/A
Upside/Downside: N/A
Short Interest: Bearish
8.47% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 1.92
Based on 2 Articles This Week
Insider Trading: Acquiring Shares
$192 Bought Last Quarter
Proj. Earnings Growth: Growing
From ($1.67) to ($0.47) Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.76 out of 5 stars

N/A

Analyst's Opinion

Consensus Rating
There is not enough analysis data for Intelligent Bio Solutions.

2.0

Short Interest

Percentage of Shares Shorted
8.47% of the float of Intelligent Bio Solutions has been sold short.
Short Interest Ratio / Days to Cover
Intelligent Bio Solutions has a short interest ratio ("days to cover") of 0.3, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Intelligent Bio Solutions has recently increased by 5.11%, indicating that investor sentiment is decreasing significantly.

0.0

Dividend Strength

Dividend Yield
Intelligent Bio Solutions does not currently pay a dividend.
Dividend Growth
Intelligent Bio Solutions does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for INBS.

4.4

News and Social Media Coverage

News Sentiment
Intelligent Bio Solutions has a news sentiment score of 1.92. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.82 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 2 news articles for Intelligent Bio Solutions this week, compared to 1 article on an average week.
Search Interest
15 people have searched for INBS on MarketBeat in the last 30 days. This is an increase of 400% compared to the previous 30 days.
MarketBeat Follows
11 people have added Intelligent Bio Solutions to their MarketBeat watchlist in the last 30 days. This is an increase of 450% compared to the previous 30 days.

1.7

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Intelligent Bio Solutions insiders have bought more of their company's stock than they have sold. Specifically, they have bought $192.00 in company stock and sold $0.00 in company stock.
Percentage Held by Insiders
Only 0.28% of the stock of Intelligent Bio Solutions is held by insiders.
Percentage Held by Institutions
Only 9.28% of the stock of Intelligent Bio Solutions is held by institutions.

1.3

Earnings and Valuation

Earnings Growth
Earnings for Intelligent Bio Solutions are expected to grow in the coming year, from ($1.67) to ($0.47) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Intelligent Bio Solutions is -0.03, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Intelligent Bio Solutions is -0.03, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Intelligent Bio Solutions has a P/B Ratio of 0.17. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Intelligent Bio Solutions Stock (NASDAQ:INBS)

Intelligent Bio Solutions Inc., a medical technology company, developing non-invasive, real-time monitoring, and diagnostic tests for patients and their primary health practitioners. It offers saliva glucose biosensor for diabetes management that measures glucose in saliva. The company also provides intelligent fingerprinting drug screening system, a revolutionizing portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields; and biosensor platform for biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. The company was incorporated in 2016 and is headquartered in New York, New York. Intelligent Bio Solutions Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.

INBS Stock Price History

30 days | 90 days | 365 days | Advanced Chart

INBS Stock News Headlines

November 27, 2023 | finance.yahoo.com

Australian Civil Construction Entity, State Road Constructions, Selects Intelligent Fingerprinting Drug Screening System as Workplace Drug Screening Solution

November 19, 2023 | uk.finance.yahoo.com

Intelligent Bio Solutions Inc. (INBS)

November 28, 2023 | Autonomix (Ad)

[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity

Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com

November 18, 2023 | americanbankingnews.com

FY2024 EPS Estimates for Intelligent Bio Solutions Inc. (NASDAQ:INBS) Lifted by Zacks Small Cap

November 15, 2023 | finance.yahoo.com

INBS: New Zealand & American Expansion

November 11, 2023 | finance.yahoo.com

Intelligent Bio Solutions First Quarter 2024 Earnings: Misses Expectations

November 9, 2023 | msn.com

What's Going On With Intelligent Bio Solutions Stock?

November 8, 2023 | finance.yahoo.com

Intelligent Bio Solutions Inc. Reports Fiscal 2024 First Quarter Financial Results and Operational Highlights

November 28, 2023 | Autonomix (Ad)

[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity

October 24, 2023 | tmcnet.com

Intelligent Bio Solutions' Innovative Drug Screening Technology Now Offered in New Zealand

October 24, 2023 | finance.yahoo.com

Intelligent Bio Solutions’ Innovative Drug Screening Technology Now Offered in New Zealand

October 5, 2023 | finance.yahoo.com

Intelligent Bio Solutions Adds Logistics Firm to Fingerprint Drug Screening Portfolio and Completes Major Milestone with Existing Client

October 4, 2023 | finance.yahoo.com

Intelligent Bio Solutions Inc. Announces Closing of $4.378 Million Underwritten Public Offering Including Partial Exercise of Underwriters’ Overallotment Option

October 4, 2023 | seekingalpha.com

Intelligent Bio Solutions announces pricing of $4M underwritten public offering

October 2, 2023 | marketwatch.com

Intelligent Bio Solutions Shares Slide Premarket on Equity Offering

October 2, 2023 | msn.com

Why Is Intelligent Bio Solutions (INBS) Stock Down 52% Today?

October 2, 2023 | finance.yahoo.com

Intelligent Bio Solutions Inc. Announces Pricing of $4,000,000 Underwritten Public Offering

September 27, 2023 | finance.yahoo.com

Intelligent Bio Solutions Obtains ISO Recertification for its Intelligent Fingerprinting Drug Screening Business

September 27, 2023 | finance.yahoo.com

Intelligent Bio Solutions Obtains ISO Recertification for its Intelligent Fingerprinting Drug Screening Business

September 21, 2023 | finance.yahoo.com

Intelligent Bio Solutions Successfully Debuts Intelligent Fingerprinting Drug Screening Solution at the 2023 Workplace Health & Safety Show in Sydney, Australia

September 8, 2023 | finance.yahoo.com

Intelligent Bio Solutions Completes Critical Development Milestone in Plans to Add Ketamine and Tramadol to Fingerprint Drug Test

September 5, 2023 | finance.yahoo.com

INBS: Australia Off to a Strong Start

August 25, 2023 | benzinga.com

Intelligent Bio Solutions (NASDAQ: INBS) Launches Global Expansion of Its Cutting-Edge Intelligent Drug Screening System

August 1, 2023 | finance.yahoo.com

Intelligent Bio Solutions Secures 8 New Customers with a Combined Workforce of Over 10,000 Employees Two Months into Product Launch in Australia

August 1, 2023 | finance.yahoo.com

Intelligent Bio Solutions Secures 8 New Customers with a Combined Workforce of Over 10,000 Employees Two Months into Product Launch in Australia

July 25, 2023 | finance.yahoo.com

Intelligent Bio Solutions Inc.'s (NASDAQ:INBS) Profit Outlook

July 11, 2023 | ecampusnews.com

Leveraging AI to Power Today’s Intelligent Campus

See More Headlines

Receive INBS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Intelligent Bio Solutions and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 11/08/2023
Today: 11/28/2023
Next Earnings (Estimated): 2/13/2024
Fiscal Year End: 6/30/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Surgical & medical instruments
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:INBS
CUSIP: N/A
CIK: 1725430
Web: gbs.inc
Phone: 646-828-8258
Fax: N/A
Employees: 51
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): ($9.13)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-10,630,000.00
Net Margins: -510.29%
Pretax Margin: -511.76%
Return on Equity: -147.23%
Return on Assets: -64.92%

Debt

Debt-to-Equity Ratio: 0.25
Current Ratio: 0.39
Quick Ratio: 0.25

Sales & Book Value

Annual Sales: $1.26 million
Price / Sales: 2.13
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $1.58 per share
Price / Book: 0.19

Miscellaneous

Outstanding Shares: 8,730,000
Free Float: 8,710,000
Market Cap: $2.68 million
Optionable: Not Optionable
Beta: 4.03

10 Best Stocks to Own in 2024

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Key Executives

Mr. Harry Simeonidis (Age 56)
President & CEO
Comp: $310.79k
Mr. Spiro Kevin Sakiris B.Bus (Age 61)
C.A., CA, Dip Law, Chief Financial Officer
Comp: $274.43k
Ms. Victoria Gavrilenko (Age 40)
Operations Manager
Comp: $45k
Mr. Alex Arzeno
VP of Investor Relations

Key Competitors

View All Competitors

Insiders

Harry Simeonidis
Bought 100 shares on 8/31/2023
Total: $192.00 ($1.92/share)

View All Insider Transactions

INBS Stock Analysis - Frequently Asked Questions

How have INBS shares performed in 2023?: Intelligent Bio Solutions' stock was trading at $3.9980 at the start of the year. Since then, INBS stock has decreased by 93.1% and is now trading at $0.2750.
View the best growth stocks for 2023 here.
When is Intelligent Bio Solutions' next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 13th 2024.
View our INBS earnings forecast.
How were Intelligent Bio Solutions' earnings last quarter?: Intelligent Bio Solutions Inc. (NASDAQ:INBS) released its quarterly earnings data on Wednesday, November, 8th. The company reported ($1.04) EPS for the quarter. The business earned $0.80 million during the quarter. Intelligent Bio Solutions had a negative trailing twelve-month return on equity of 147.23% and a negative net margin of 510.29%.

When did Intelligent Bio Solutions' stock split?: Intelligent Bio Solutions's stock reverse split on Friday, February 10th 2023. The 1-20 reverse split was announced on Friday, February 10th 2023. The number of shares owned by shareholders was adjusted after the market closes on Friday, February 10th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.
How do I buy shares of Intelligent Bio Solutions?: Shares of INBS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NASDAQ:INBS) was last updated on 11/28/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial